Dyadic is interested in strategic partnerships with the industry leaders in various sectors, including pharmaceuticals, agricultural and food products, chemicals and fibers, diagnostics, health and beauty aids, and animal feed and health products.

Dyadic works with its partners to discover new biomaterials, develop new products, lower costs and reduce waste, improve yields, enhance the quality of end products, enhance the intellectual property position of its partners’ gene discoveries and gene products, and manufacture biological products.

The business relationship with Dyadic can cover all aspects of the process from gene and protein discovery to commercial scale manufacturing for a partner, or just any one aspect of this R&D and commercialization process (view diagram).

Partnerships can take any appropriate form, including but not limited to:
- Funded R&D with license for commercial rights for resulting products (with or without Dyadic manufacturing products for the partner)
- Joint ventures in defined fields for discovering, developing, manufacturing and commercializing products emanating from the application of Dyadic’s genomics technology

Dyadic is developing functional biomolecule libraries for other companies to access – under suitable business arrangements – to screen for products of commercial value. When desired by a business partner, Dyadic will screen soil samples and other sources for novel eukaryotic genes and proteins of commercial value.

Dyadic is also interested in collaboration with independent researchers, as well as scientists at research institutions, universities and commercial establishments where a research partnership is of mutual benefit.

Also if you are interested in Dyadic’s manufacturing capabilities for your biological products, please visit Manufacturing Services.